June 06, 2023
2 min watch
Save
VIDEO: Iheezo provides new anesthesia option for ocular surgery
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Key takeaways:
- Iheezo has a three-drop dosing protocol and will last for about 20 minutes.
- Iheezo is FDA approved and has a J-code associated with it, making it billable through insurance.
KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Maggie Jeffries, MD, shares why Iheezo is a reliable ocular surface anesthetic option and gives tips on how to use it.
“The studies have shown that in patients using Iheezo, they didn’t need any additional topical ocular anesthetics during surgery, so it was a 100% success rate,” she said.
Iheezo (chloroprocaine hydrochloride ophthalmic gel 3%, Harrow) was approved by the FDA in 2022.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Jeffries reports having relevant financial disclosures for Harrow.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.